La Jolla Pharmaceutical (LJPC) Announces $10M Share Repurchase Plan

La Jolla Pharmaceutical Company (Nasdaq: LJPC) today announced that it will commence a share repurchase plan for up to $10 million of the Company’s common stock. Repurchases may be made from time to time at the Company’s discretion. The plan has no time limit and can be discontinued at any time. There can be no assurance as to the timing or number of shares of any repurchases.

“The decision to repurchase shares reflects our confidence in our team and the ability to execute against our strategic initiatives for growth, which is supported by the strength of our balance sheet,” said Larry Edwards, President and Chief Executive Officer of La Jolla.

You May Also Be Interested In

• Reitar Logtech launches $3M share repurchase program
• James Hardie sells Fermacell unit to Holcim for €840 million
• Almonty Industries launches $300M share repurchase program